| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.51▲ | 2.51▲ | 2.51▲ | 2.48▼ | 2.23▲ |
| MA10 | 2.47▲ | 2.47▲ | 2.45▲ | 2.41▲ | 2.30▲ |
| MA20 | 2.33▲ | 2.30▲ | 2.27▲ | 2.20▲ | 2.64▼ |
| MA50 | 2.19▲ | 2.25▲ | 2.25▲ | 2.29▲ | 2.91▼ |
| MA100 | 2.27▲ | 2.34▲ | 2.36▲ | 2.61▼ | 2.87▼ |
| MA200 | 2.43▲ | 2.69▼ | 2.82▼ | 2.80▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.020▲ | 0.028▲ | 0.036▲ | 0.040▲ | -0.008▼ |
| RSI | 72.552▲ | 68.262▲ | 68.042▲ | 55.932▲ | 45.736▼ |
| STOCH | 88.115▲ | 88.457▲ | 91.966▲ | 87.641▲ | 43.695 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -20.635▲ | -50.000 |
| CCI | 80.053 | 79.381 | 86.308 | 46.458 | 29.873 |
|
Sunday, April 27, 2025 05:00 PM
Catalent to evaluate certepetide with its SMARTag® antibody-drug conjugate platformBASKING RIDGE, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata ...
|
|
Saturday, April 26, 2025 07:51 AM
But the harsh reality is that very many loss making companies burn through all their cash and go bankrupt. So should Lisata Therapeutics (NASDAQ:LSTA) shareholders be worried about its cash burn? In ...
|
|
Tuesday, April 15, 2025 01:00 AM
BASKING RIDGE, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 2.42 | 2.4359 | 2.355 | 2.41 | 3,500 |
| 30/04/25 | 2.45 | 2.5254 | 2.3602 | 2.37 | 6,040 |
| 29/04/25 | 2.54 | 2.54 | 2.50 | 2.54 | 10,804 |
| 28/04/25 | 2.4895 | 2.54 | 2.40 | 2.53 | 19,196 |
| 25/04/25 | 2.43 | 2.53 | 2.31 | 2.53 | 9,602 |
| 24/04/25 | 2.43 | 2.46 | 2.38 | 2.44 | 7,354 |
| 23/04/25 | 2.30 | 2.4305 | 2.29 | 2.3546 | 4,438 |
| 22/04/25 | 2.29 | 2.4297 | 2.29 | 2.34 | 8,998 |
| 21/04/25 | 2.24 | 2.3299 | 2.13 | 2.28 | 26,865 |
| 17/04/25 | 2.24 | 2.2556 | 2.08 | 2.2556 | 5,330 |
|
|
||||
|
|
||||
|
|